In spite of improvements in surgical technique and myocardial preservation, low cardiac output occasionally presents a problem following cardiopulmonary bypass (CPB) for coronary artery surgery. Low cardiac output in combination with ischaemic heart disease is associated with a poor prognosis. I The combined use of inotropic agents and vasodilators has proved useful in patients with severe left ventricular dysfunction. Use of vasodilator therapy, however, may be limited by the occurrence of hypotension and patients with ischaemic heart disease may be sensitive to the chronotropic and dysrhythmogenic effects of catecholamines. We report the successful management of such a case with the combined use of noradrenaline, amrinone and nitroglycerin.
CASE REPORT
An obese 56-year-old man, weighing 98 kg, with a five-year history of chest pain, was admitted to the coronary intensive care unit with crescendo angina. Past medical history included asthma, chronic obstructive airway disease, hypertension, and smoking. The patient's medications included diltiazem, metoprolol, theophylline, isosorbide dinitrate, sublingual nitroglycerin and daily use of an albuterol inhaler. The ECG showed normal sinus rhythm with occasional ventricular ectopic beats and ST depression in leads Ill, A VF and V6. Coronary angiography demonstrated 70% occlusion of the left main coronary artery, 85% occlusion of the left anterior descending artery, 70% occlusion of the marginal branch, and 100% occlusion of the right coronary artery. Left ventricular ejection fraction was 63%. The patient was scheduled for triple aortocoronary artery bypass surgery.
Anaesthesia was induced uneventfully with sufentanil 5 Ilg/kg, vecuronium 0.2 mg/kg and 100% oxygen. Sufentanil infusion and intermittent isoflurane were used for maintenance. Following administration of heparin, CPB was instituted and cold, hyperkalaemic cardioplegia was used to arrest the heart. Perfusion pressure was maintained between 50 and 70 mmHg and urine output during bypass was 50-100 mllhour. Total aortic cross-clamp time was 76 minutes. The right coronary artery was not bypassed because of significant calcification in the distal coronary artery.
During weaning from CPB, the heart was markedly hypoactive, even with atrioventricular sequential pacing. Dobutamine (10 Ilg/kg/min) in conjunction with a low-dose nitroglycerin infusion up to 1 Ilg/kg/min was initiated without success. When adrenaline (3 Ilg/min) was substituted for the dobutamine, myocardial contractility improved, but this was followed by a supraventricular tachycardia (SVT) of 160 beats/min and a systolic blood pressure of 50 mmHg. The adrenaline was discontinued. An esmolol infusion successfully converted the SVT to normal sinus rhythm (90-100 beats/ min); however, the heart was noted to be dilated and the esmolol was discontinued.
Multiple attempts were made to wean from CBP with the combination of dopamine, dobutamine and nitroglycerin without success. A systolic blood pressure of 90-100 mmHg was eventually maintained with a noradrenaline infusion up to 0.04 Ilg/kg/min, followed by a bolus dose of infusion of amrinone (7 Ilg/kg/min), resulting in an improvement of ventricular contractility. The patient was weaned off CPB with noradrenaline 0.02-0.04 Ilg/kg/min, amrinone 7 Ilg/kg/min and nitroglycerin 0.5 Ilg/kg/min. Arterial pressure was in the range of 100-120/ 70-80 mmHg, cardiac output 4-5 lImin, and heart rate 90-100 beats/min with normal sinus rhythm. Systemic vascular resistance was in the range of 1200 to 1550 dyn.sec.cm- 5 . In the surgical intensive care unit, the cardiac output had improved and arterial pressure and heart rate were essentially unchanged. On the first postoperative day, the patient was weaned from the noradrenaline and the amrinone was reduced to 3 Ilg/kg/min. On the third postoperative day, amrinone was discontinued. Equilibrium multiple-gated blood pool scintigraphy showed a left ventricular ejection fraction of 47% with a slightly enlarged left ventricle. BUN and creatinine were checked daily until discharge and stayed in the range of 5-6.1 mmolll and 100-120 Ilmolll respectively. He was discharged on the 15th postoperative day.
DISCUSSION
Although rare, low cardiac output syndrome continues to be a serious challenge following coronary artery surgery. I Inotropic drugs such as dopamine and dobutamine alone or with vasodilators have been used successfully in this condition. 2 Dopamine has its positive inotropic effect by cardiac betareceptor stimulation. Although useful in patients with ischaemic heart disease and ventricular dysfunction, dopamine may cause excessive tachycardia, dysrhythmias and an increase in myocardial oxygen demand. 3 Dobutamine has a potent positive inotropic action with little effect on vascular tone and with less of a chronotropic effect than naturally occurring sympathomimetic amines. Dobutamine is a racemic mixture ofL and D isomers. The L-isomer is a potent alpha-adrenergic agonist and a relatively weak beta-adrenergic agonist,3 whereas the D-isomer is a potent beta-l and beta-2 agonist. 3 Noradrenaline has significant beta-l receptor activity in the myocardium. 3 Alpha-l adrenergic receptors are also abundant in the myocardium and cause increased contractility when stimulated. 3 In contrast to beta-l stimulation, this alpha-l receptor stimulation does not increase sinoatrial automaticity and is characterised by a slow heart rate independent of beta-l receptor effect. 3 Also alpha-l receptor mediated vasoconstriction can improve coronary perfusion by increasing or maintaining diastolic blood pressure. There may be less tachycardia with the use of noradrenaline than with other inotropic agents due to its alpha-adrenergic activity in the heart and also reflex baroreceptor stimulation. 3 Excessive alpha-receptor mediated vasoconstriction may, however, increase afterload significantly to worsen the failing heart. Tolerance to the effect of noradrenaline may also occur in the failing heart due to a decrease in the density of beta receptors in the myocardium and secondary to an uncoupling of beta receptors from adenyl cyclase. 3 Amrinone, a nonglycosidic, noncatecholamine phosphodiesterase F III inhibitor, exerts potent inotropic as well as vasodilator activity while rate is left essentially unchanged. 4 Amrinone therefore reduces wall tension and lowers myocardial oxygen consumption in spite of increased contractility. 5 Inotropic effects of amrinone may be additive or synergistic with other betaadrenergic agonists. The synergistic effects of amrinone with dobutamine or dopamine have been documented in the treatment of low cardiac output after open heart surgery. 6 Amrinone may counteract the vasoconstrictive effect of noradrenaline but also may act synergistically with its inotropic effect. 4 The combined use of inotropic agents and vasodilators helps to restore cardiac function. Amrinone and nitroglycerin, in combination, enhance right ventricular function by reducing pulmonary vascular resistance and increasing right ventricular contractility. 5.7.8 In this case, noradrenaline was used to increase arterial pressure in order to improve Anaesthesia and Intensil'e Care. Vol. 16. No. 4. NOI·ember. 1988 coronary perfusion without increasing heart rate. 4 The amrinone was used to increase ventricular function without increasing heart rate, not to augment the inotropic effect of noradrenaline but to counteract the excessive vasoconstrictive effect of noradrenaline. 7 Noradrenaline in combination with nitroglycerin may further increase coronary blood flow, especially subendocardial coronary blood flow. s In summary, combined use of noradrenaline, amrinone and nitroglycerin may significantly improve severe low cardiac output states following CBP by increasing coronary blood flow, augmenting contractility, and improving left and right ventricular function when used judicially. We also demonstrate that normal renal function can be maintained with a noradrenaline, amrinone and nitroglycerin combination by optimising preload and providing adequate cardiac output.
